HDAC inhibitors have wide ranging therapeutic value and have been considered for the treatment of cancer (5) and neurodegenerative disorders (6), as well as in “shock and kill” strategies to facilitate an HIV cure (7). The gene discussed is HDAC9; the disease is cancer.